Results 191 to 194 of about 46,982 (194)

Unproven Methods of Cancer Treatment: Rand Coupled Fortified Antigen (RCFA) and Delayed Double Diffusion (3-D) Test

Ca-A Cancer Journal for Clinicians, 1969
exaly  

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells

European Journal of Immunology, 1996
van Dijk, A.M.C., Otten, H.G., Vercauteren, S.M., Kessler, F.L., Verdonck, L.F., de Boer, M., de Gast, G.C.   +6 more
openaire   +1 more source

RORγt+ antigen-presenting cells mediate food tolerance

Nature Reviews Immunology
exaly  

NOVEL MAMMAL-ORIGIN PROTEIN NEGATIVELY REGULATING THE EXPRESSION OF ANTIGEN PRESENTATION-ASSOCIATED MOLECULE SUCH AS B7-2 MOLECULE OR MHC CLASS II MOLECULE ON CELL SURFACE AND UTILIZATION OF THE SAME

2004
openaire   +1 more source